| Mepha Pharma AG - Oxycodon-Naloxon-Mepha 30 mg/15 mg, Retardtabletten | | 65742 | | 05 | | Oxycodon-Naloxon-Mepha 30 mg/15 mg | | Retardtabletten | | N02AA55 | | Oxycodone and Naloxone | | 28.01.2019 | | |
| | Composition | | oxycodoni hydrochloridum 30 mg, naloxoni hydrochloridum anhydricum 15 mg ut naloxoni hydrochloridum dihydricum, poly(vinylis acetas), povidonum K 30, natrii laurilsulfas corresp. natrium 0.05 mg, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, E 171, macrogolum 3350, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés retards | | | | Principe actif | Concentr. |
|---|
| Naloxone Hydrochloride Anhydre | 15 mg | | Oxycodon-Hydrochlorid | 30 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Macrogol | 3350 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Poly(Vinylis Acetas) | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 009 | 30 | DDP | DDP | A+ | | Oui | | 010 | 60 | DDP | DDP | A+ | | Oui |
|
|
